HYPOPHOSPHATEMIA 

1. Definition

Hypophosphatemia = serum phosphate < 2.5 mg/dL (0.81 mmol/L)

Severity

Serum Phosphate

Mild

2.0–2.5 mg/dL

Moderate

1.0–1.9 mg/dL

Severe (life-threatening)

< 1.0 mg/dL (<0.32 mmol/L)

Symptoms usually appear when <1 mg/dL

2. Functions of phosphate 

  1. ATP synthesis → cellular energy
  2. 2,3-DPG in RBCs → oxygen delivery
  3. Cell membrane integrity (phospholipids)
  4. Buffering system
  5. Muscle contraction (including diaphragm)

3. Regulation of Phosphate Homeostasis

Intestinal absorption

  • Vitamin D–dependent
  • Increased by calcitriol

Renal handling (MOST IMPORTANT)

  • Proximal tubule reabsorption (Na-Pi cotransporters)
  • Normal excretion: <10% filtered load

Hormonal regulation

Hormone

Effect

PTH

↓ renal phosphate reabsorption

FGF-23

↓ phosphate reabsorption + ↓ vitamin D

Vitamin D

↑ intestinal absorption

Insulin

↑ intracellular shift

4. Etiology – CLASSIFICATION 

A. Decreased Intestinal Absorption

Cause

Mechanism

Malnutrition, starvation

Low intake

Chronic alcoholism

Poor intake + renal loss

Vitamin D deficiency

↓ absorption

Antacids (Al, Mg, Ca)

Phosphate binding

Chronic diarrhea

GI loss

Bariatric surgery

Malabsorption

B. Increased Renal Phosphate Loss (COMMON IN ICU)

1. Hormonal

  • Hyperparathyroidism
  • Tumor-induced osteomalacia (↑ FGF-23)

2. Tubular dysfunction

  • Fanconi syndrome
  • Proximal RTA
  • Post-ATN diuretic phase

3. Drugs 

  • Diuretics
  • Aminoglycosides
  • Cisplatin
  • Tenofovir
  • Amphotericin B
  • Acetazolamide

C. Intracellular Shift (MOST COMMON CAUSE IN ICU)

Cause

Mechanism

Refeeding syndrome

Insulin-mediated cellular uptake

DKA treatment

Insulin + glucose

Respiratory alkalosis

↑ glycolysis → phosphate uptake

Sepsis

Cytokine-mediated shift

Acute leukemia treatment

Cellular uptake

Total body phosphate may be depleted even if initial serum level normal

5. Clinical Manifestations 

A. Neuromuscular (MOST COMMON)

  • Proximal myopathy
  • Respiratory muscle weakness → ventilator failure
  • Rhabdomyolysis
  • Paresthesia
  • Tremors

 Weaning failure from ventilator – think hypophosphatemia


B. CNS

  • Irritability,Confusion,Delirium,Seizures,Coma

C. Cardiovascular

  • Decreased myocardial contractility
  • Heart failure,Arrhythmias,Hypotension

D. Hematologic

Effect

Mechanism

Hemolysis

↓ RBC ATP

Leukocyte dysfunction

↓ phagocytosis

Thrombocytopenia

↓ platelet aggregation


7. Diagnosis & Evaluation

Serum phosphate-Morning sample preferred

Associated labs 

Test

Reason

Calcium

Reciprocal relationship

Magnesium

Commonly low

Potassium

Refeeding

Vitamin D

Malabsorption

PTH

Renal loss

ABG

Respiratory alkalosis

Renal vs Non-renal Loss 

Fractional Excretion of Phosphate (FEPO₄)

  • <5% → redistribution / poor intake
  • >5–10% → renal wasting

8. Management 

A. When to Treat? (VERY IMPORTANT)

Situation

Treat?

<2.5 mg/dL asymptomatic

Oral

<1.0 mg/dL

IV mandatory

ICU patient

Treat aggressively

Ventilated patient

Treat even mild

9. Phosphate Replacement 

A. ORAL PHOSPHATE (Mild–Moderate)

  • Sodium or potassium phosphate
  • Dose: 30–60 mmol/day in divided doses
  • Side effects:
    • Diarrhea
    • Hyperphosphatemia (rare)


B. INTRAVENOUS PHOSPHATE (CRITICAL CARE)

Indications

  • Serum phosphate <1 mg/dL
  • Respiratory failure
  • Rhabdomyolysis
  • Hemolysis
  • Sepsis
  • Refeeding syndrome

Choice of preparation

Situation

Use

Hypokalemia

Potassium phosphate(Each 1 mmol of phosphate contains ~1.5 mEq of potassium;)

Hyperkalemia / renal failure

Sodium phosphate


IV Dosing 

  • Phosphorus content: 93mg (3mM)/mL
  • Potassium content: 170mg (4.4 mEq)/mL

Serum Phosphate

Dose

<1 mg/dL

0.32–0.64 mmol/kg IV

1–2 mg/dL

0.16–0.32 mmol/kg IV
  • Maximum single dose: 45 mmol
  • Infusion rate: ≤7.5 mmol/hour
  • Dilute in 250–500 mL NS/D5W

Monitoring 

  • Serum phosphate 6–12 hourly
  • Calcium (risk of hypocalcemia)
  • Magnesium
  • ECG monitoring

10. Complications of Phosphate Therapy

Complication

Mechanism

Hypocalcemia

Calcium-phosphate precipitation

Hypotension

Rapid infusion

Acute kidney injury

Nephrocalcinosis

Metastatic calcification

Excess dosing